Literature DB >> 10504477

Telomerase activity and telomere lengths: alterations in renal cell carcinomas.

R Dahse1, W Fiedler, K Junker, A Schlichter, J Schubert, U Claussen.   

Abstract

Detection of telomerase activity in renal cell carcinomas may be a key to understanding the loss of growth control in tumor cells. This enzyme forms the end of most chromosomal DNAs (that is, telomeres) found in renal tumors. When activated, the telomeres shorten with every cell cycle and then there is a compensatory lengthening of the cells, which then proliferate and eventually become immortal and metastasize. This complex multigenetic process may prove to be a useful marker of tumor progression and patient outcome.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10504477     DOI: 10.1046/j.1523-1755.1999.00688.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  5 in total

1.  High telomerase activity correlates with the stabilities of genome and DNA ploidy in renal cell carcinoma.

Authors:  Hideki Izumi; Takahiko Hara; Atsunori Oga; Kenji Matsuda; Yuko Sato; Katsusuke Naito; Kohsuke Sasaki
Journal:  Neoplasia       Date:  2002 Mar-Apr       Impact factor: 5.715

2.  Expression of TRF1, TRF2, TIN2, TERT, KU70, and BRCA1 proteins is associated with telomere shortening and may contribute to multistage carcinogenesis of gastric cancer.

Authors:  Hua Hu; Yang Zhang; Mei Zou; Shuai Yang; Xiao-Qiu Liang
Journal:  J Cancer Res Clin Oncol       Date:  2010-02-02       Impact factor: 4.553

3.  Genome-wide profiling of chromosomal alterations in renal cell carcinoma using high-density single nucleotide polymorphism arrays.

Authors:  Meng Chen; Yuanqing Ye; Hushan Yang; Pheroze Tamboli; Surena Matin; Nizar M Tannir; Christopher G Wood; Jian Gu; Xifeng Wu
Journal:  Int J Cancer       Date:  2009-11-15       Impact factor: 7.396

4.  Roles of telomeres and telomerase in age‑related renal diseases (Review).

Authors:  Haili Li; Boyuan Wang; Daoqun Li; Jinyuan Li; Ying Luo; Juhua Dan
Journal:  Mol Med Rep       Date:  2020-12-10       Impact factor: 2.952

5.  Telomere shortening and mitotic dysfunction generate cytogenetic heterogeneity in a subgroup of renal cell carcinomas.

Authors:  D Gisselsson; L Gorunova; M Höglund; N Mandahl; P Elfving
Journal:  Br J Cancer       Date:  2004-07-19       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.